Rapport Therapeutics Inc (RAPP)
EBITDA Margin
-741.82%
TTM · Period ending:
RAPP EBITDA Margin
Latest reported-741.82%period ending
Latest reported-741.82%period ending
RAPP TTM EBITDA Margin (-606.03% → -741.82%)
TTM ebitda margin
High-resolution chart · PNG
RAPP ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| -741.825% | |
| -606.03% |